COLLEGE OF ALLIED HEALTH SCIENCES

A.Y. 2020-2021

CASE STUDY: CORONAVIRUS DISEASE (COVID-19)

A partial fulfillment for the requirements in _______________________________,

(Course)

____________________, ____________________
(Year Level) (Semester)

Submitted to:

_______________________________________
(Name of Program Head)

Submitted by:

_______________________________________
(Last Name, First Name, Middle Initial)

_______________________
(Date of Submission)
 2

CASE SCENARIO
(This is your case for this study. All the information that will be written should be based
from this scenario.)

A 65-year-old male resident of 26 Project 7, Molo St, Mangaldan, Manila, Mr.

Covid King Quarantino, presents with fever and cough. He was well until 3 days earlier

when he suffered the onset of nasal stuffiness, mild sore throat, and a dry cough. Today,

he decided to seek physician assistance because of an increase in temperature to

38.5°C and feelings of fatigue, watery stools for 4 times today already, and back pain

(rated as 7 out of 10 on a pain scale).

He is a retired police officer and lives with his wife and 3 children, aged 7, 9, and

11 years. The children are fully immunized. The patient has traveled outside the town

and confirms contact with a known Covid-19 positive patient 10 days before the onset of

signs and symptoms. He has no history of familial illness, hospitalizations, or trauma.

There are no drug allergies or intolerance. The only medication he takes is

acetaminophen occasionally, for headaches. He drinks beer or wine in moderation.

Upon assessment, his body temperature is 38.5°C (101.3°F), his blood pressure

is 130/80 mmHg, his pulse is 86 beats/min and regular, and his respiratory rate is 27

breaths/min. His oxygen saturation is 93% while breathing room air. There is shortness

of breath even at rest. His hemoglobin is 124 g/L, with a hematocrit of .38 (38%), WBC

count is 13.2 cells/µL, with 82% polymorphonuclear cells, 11% band forms, and 36%

lymphocytes. His urea is 8.65 mmol/L, with a creatinine of 141.50 µmol/L. Chest x-ray

shows both lungs that are consistent with pneumonia but was unable to rule out,

correlation with clinical and laboratory parameters is suggested. With well-defined

opacity in the right upper lung as described may represent pulmonary mass. Moreover,

laboratory findings are added below for reference.

The patient was given oxygen via nasal cannula at 8 liters per minute with

reserved mechanical ventilation if an arrest occurs. The patient was also given
 3

azithromycin for CAP-MR, dexamethasone for alveolar inflammation, paracetamol for

fever, and N-Acetylcysteine for his dry cough. He also consented to undergo a solidarity

clinical trial to help find an effective treatment for COVID-19. He has been given

remdesivir and lopinavir. The solidarity trial aims to rapidly discover whether any drugs

slow disease progression or improve survival of the said viral infection.

LABORATORY RESULT FORM

TEST RESULT UNIT REFERENCE

RANGES

IMMUNOHEMATOLOGY

Complete Blood Count

WBC 13.2 4.0 – 10.0
Differential Count
Neutrophils 69.5 % 55.0 – 65.0
Lymphocytes 36.6 % 25.0 – 35.0
Monocytes 6.9 % 3.0 – 6.0
Eosinophils 1.6 % 2.0 – 4.0
Basophils 0.6 % 0.0 – 1.0
Erythrocytes 4.4 x10^9/L 4.0 – 5.4
Hemoglobin 124 g/L 120 – 160
Hematocrit 0.38 0.37 – 0.47
MCV 86.4 fL 80.0 – 100.0
MCH 28.2 Pg 27.0 – 34. 0
MCHC 326 g/L 310 – 370
RDW-CV 13.3 % 11.0 – 16.0
RDW-SD 41.8 fL 35.0 – 56.0
Platelet Count 339 x10^9/L 150 – 450
MPV 10.0 fL 6.5 – 12.0
PDW 11.1 9.0 – 17.0
 4

PCT 0.340 mL/L 0.108 – 0.282

CLINICAL CHEMISTRY

UREA 8.65 mmol/L 1.67 – 8.35

Sodium 133.90 mmol/L 135.0 – 148.0
Potassium 4.49 mmol/L 3.50 – 5.30
Chloride 102.20 mmol/L 98.0 – 107.0
Ionized Calcium 1.31 mmol/L 1.13 – 1.32
Creatinine 141.50 umol/L 61.89 – 123.79

RADIOLOGY DEPARTMENT
X-RAY SECTION

EXAMINATION: CHEST PA (ADULT)

CHEST X-RAY (AP SITTING VIEW)

The lungs are hyperaerated

Hazy and streaky densities in both lungs more in the right upper lung.

Fairly defined opacity is also noted on the right upper lung.

Heart is not enlarged. Aorta is not unusual.

Tenting deformities are seen in right hemidiaphragm.

Both costophrenic sulci are blunt.

The visualized bones of the thorax are intact.

IMPRESSION:

Both lungs although concomitant pneumonia cannot be totally ruled out.

Correlation with clinical and laboratory parameters is suggested.

 5

Well defined opacity in right upper lung as described may represent pulmonary

mass. Lateral view is suggested for further evaluation.

Tenting deformities, right suggestive of pleurodiaphragmatic adhesion.

Consider minimal bilateral fluid and/or thickening.

Remarks: This result is best interpreted by your attending physician in correlation with
the clinical diagnosis of other ancillary procedures.

ABSTRACT

(In this part, you write a brief statement of 150 words or less which concisely reports and
summarizes the content of this case study.)
 6

TABLE OF CONTENTS

Page

Abstract……………………………………………………………………………………….

Table of Contents……………………………………………………………………………

Significance of the Case Study…………………………………………………………….

Patient Profile………………………………………………………………………………...

Etiologic Factors……………………………………………………………………………..

Clinical Manifestations………………………………………………………………………

Pathophysiology……………………………………………………………………………..

Laboratory and Diagnostic Tests…………………………………………………………..

Medical Management………………………………………………………………………..

Care Plans……………………………………………………………………………………

References…………………………………………………………………………………...
 7

SIGNIFICANCE OF THE CASE STUDY

(This section essentially pertains to its importance and on how this case study can
contribute to the field of education, practice, and research. You write the vital role of this
study to your chosen profession.)

In Education

In Practice

In Research
 8

PATIENT PROFILE
(From the case scenario presented, you fill out the required information in this part.)

I. BIOGRAPHIC DATA

Patient’s Name: ______________________________________

Age: ______________________________________

Sex: ______________________________________

Address: ______________________________________

Civil status: ______________________________________

Occupation: ______________________________________

Religion: ______________________________________

Date of admission: ______________________________________

II. CHIEF COMPLAINTS

III. HISTORY OF THE PRESENT ILLNESS

 9

IV. PAST MEDICAL HISTORY

V. VITAL SIGNS

a. Temperature: _________

b. Pulse Rate: _________

c. Respiratory Rate: _________

d. Blood Pressure: _________

e. Pain Scale: _________

VI. REVIEW OF ANATOMY & PHYSIOLOGY OF RESPIRATORY SYSTEM

(In this part, you identify and illustrate the physiologic and structural components of
respiratory system which is mainly affected by the presence of virus. Through this, you
can view its impact to the normal functioning of the system compromised.)
 10

VII. MEDICAL DIAGNOSIS

(You write in this area the official medical diagnosis made by the physician in the case
scenario provided. Moreover, a brief definition of the disease can be added to provide its
general view.)
 11

ETIOLOGIC FACTORS
(You identify and list the different factors causing or contributing to the cause of the
disease or condition based from the case scenario. You organize these factors into two
groups: the predisposing and precipitating etiologic factors, sub-grouping them into
modifiable and non-modifiable risk factors. First, you define each classification
accordingly.)

▪ Predisposing Factors
________________________________________________________________
________________________________________________________________
________________________________________________________________

▪ Precipitating Factors
________________________________________________________________
________________________________________________________________
________________________________________________________________

▪ Modifiable Factors
________________________________________________________________
________________________________________________________________
________________________________________________________________

▪ Non-Modifiable Factors
________________________________________________________________
________________________________________________________________
________________________________________________________________

Predisposing Factors Precipitating Factors

Modifiable Non-Modifiable Modifiable Non-Modifiable

 12

CLINICAL MANIFESTATIONS
(These are list of signs and symptoms that are perceived by the client in the current
situation. You enlist these manifestations into subjective and objective data. First, you
define each type of data accordingly)

▪ Subjective Data
________________________________________________________________
________________________________________________________________
________________________________________________________________

▪ Objective Data
________________________________________________________________
________________________________________________________________
________________________________________________________________

Subjective Data Objective Data

 13

PATHOPHYSIOLOGY
(This part discusses the nature of the disease as it affects the normal functioning of the
body systems. You utilize the process of concept mapping in disease presentation. A
concept map is a visual organization and representation of knowledge. Ideally, it starts
with etiology and ends with complications or recovery.)

Etiologic Factors

CORONA VIRUS
DISEASE 2019
(COVID – 19)
Etiologic Agent Mode of
Transmission

Pathophysiology (1)

Pathophysiology (2)

Pathophysiology (3)

Pathophysiology (4)
 14

Pathophysiology (5)

Pathophysiology (6)

Pathophysiology (7)

Pathophysiology (8)

Pathophysiology (9)
 15

Most Common Diagnostic

Symptoms: Studies/Tests

Less Common
Symptoms:

Complications

Pharmacologic Medical
Management Management
 16

LABORATORY AND DIAGNOSTIC TESTS

(From the case scenario presented, you write and enlist here the significant laboratory
and diagnostic tests with their values. You also indicate how these values are
interpreted with the client’s case.)

Test Done to the Client Interpretation

 17

MEDICAL MANAGEMENT
(Use this part for the drug study of each medication presented in the client’s case. The generic name of the medication has already
been indicated. You simply complete the drug study by filling out the remaining information needed.)

Classification/ Side effects/ Adverse

Drug Name Indications Contraindications
Mechanism of Action Effects
Generic Name: Classification:

Remdesivir
Mechanism of Action:

Brand Name:

Route:

Dosage
 18

Frequency:

Classification/ Side effects/ Adverse

Drug Name Indications Contraindications
Mechanism of Action Effects
Generic Name: Classification:

Azithromycin
Mechanism of Action:
 19

Brand Name:

Route:

Dosage

Frequency:
 20

Classification/ Side effects/ Adverse

Drug Name Indications Contraindications
Mechanism of Action Effects
Generic Name: Classification:

Lopinavir/Ritonavir
Mechanism of Action:

Brand Name:

Route:
 21

Dosage

Frequency:
 22

Classification/ Side effects/ Adverse

Drug Name Indications Contraindications
Mechanism of Action Effects
Generic Name: Classification:

Dexamethasone
Mechanism of Action:

Brand Name:

Route:

Dosage
 23

Frequency:

Classification/ Side effects/ Adverse

Drug Name Indications Contraindications
Mechanism of Action Effects
Generic Name: Classification:
 24

Paracetamol

Mechanism of Action:

Brand Name:

Route:

Dosage

Frequency:
 25

Classification/ Side effects/ Adverse

Drug Name Indications Contraindications
Mechanism of Action Effects
Generic Name: Classification:

Acetylcysteine
Mechanism of Action:

Brand Name:
 26

Route:

Dosage

Frequency:
 27

CARE PLANS
(You will be making care plans based on your assessment of care priority as aligned to your course. You can utilize numerous
problems/diagnoses. You prepare at least 3 problem-focused diagnoses.)

PROBLEM
ASSESSMENT PROBLEM PLANNING INTERVENTIONS RATIONALE EVALUATION
ANALYSIS
 28

PROBLEM
ASSESSMENT PROBLEM PLANNING INTERVENTIONS RATIONALE EVALUATION
ANALYSIS
 29

PROBLEM
ASSESSMENT PROBLEM PLANNING INTERVENTIONS RATIONALE EVALUATION
ANALYSIS
 30

PROBLEM
ASSESSMENT PROBLEM PLANNING INTERVENTIONS RATIONALE EVALUATION
ANALYSIS
 31

PROBLEM
ASSESSMENT PROBLEM PLANNING INTERVENTIONS RATIONALE EVALUATION
ANALYSIS
32
 33

REFERENCES
(You will list down all the references used for this case study in the format of APA, 6th
edition.)